Teladoc Health, Inc. (NYSE:TDOC) Given Average Rating of "Hold" by Brokerages

Key Points

• Teladoc Health, Inc. has received an average rating of "Hold" from 19 research firms, with 12 rating it as a hold and 7 providing a buy recommendation, reflecting cautious optimism about its future.
• Following a recent earnings report, Teladoc Health showcased a slight revenue increase of $631.90 million, surpassing analyst expectations, but also noted a decrease in earnings year-over-year.
• Insider transactions revealed significant selling activity, with key insiders reducing their stakes in the company, indicating potential concerns or strategic repositioning among current leadership.

Shares of Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) have earned a consensus recommendation of "Hold" from the nineteen research firms that are presently covering the company, MarketBeat reports. Twelve analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 12-month price objective among brokers that have issued a report on the stock in the last year is $9.7639.

TDOC has been the subject of several research reports. Truist Financial decreased their target price on Teladoc Health from $10.00 to $9.00 and set a "hold" rating for the company in a research report on Tuesday, May 27th. Mizuho initiated coverage on Teladoc Health in a research report on Friday, July 25th. They issued a "neutral" rating and a $10.00 target price for the company. Citigroup decreased their target price on Teladoc Health from $11.00 to $8.75 and set a "neutral" rating for the company in a research report on Friday, April 25th. Jefferies Financial Group decreased their target price on Teladoc Health from $10.00 to $8.00 and set a "hold" rating for the company in a research report on Monday, April 21st. Finally, Bank of America reduced their price objective on Teladoc Health from $8.00 to $7.00 and set a "neutral" rating for the company in a research report on Wednesday, May 28th.

Teladoc Health Trading Up 2.9%

Shares of NYSE TDOC traded up $0.21 during midday trading on Friday, reaching $7.51. The company had a trading volume of 5,729,024 shares, compared to its average volume of 7,944,137. Teladoc Health has a one year low of $6.35 and a one year high of $15.21. The company has a quick ratio of 2.58, a current ratio of 2.67 and a debt-to-equity ratio of 0.70. The firm's fifty day moving average price is $7.72 and its 200-day moving average price is $8.31. The stock has a market cap of $1.33 billion, a PE ratio of -6.31 and a beta of 1.76.

Teladoc Health (NYSE:TDOC - Get Free Report) last released its earnings results on Tuesday, July 29th. The health services provider reported ($0.19) earnings per share for the quarter, beating analysts' consensus estimates of ($0.27) by $0.08. The company had revenue of $631.90 million during the quarter, compared to analyst estimates of $621.91 million. Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.16%. Teladoc Health's revenue for the quarter was down 1.6% on a year-over-year basis. During the same quarter in the previous year, the company posted ($0.38) EPS. On average, equities research analysts anticipate that Teladoc Health will post -1.16 earnings per share for the current year.

Insiders Place Their Bets

In other Teladoc Health news, insider Adam C. Vandervoort sold 5,808 shares of the stock in a transaction dated Monday, June 2nd. The stock was sold at an average price of $6.86, for a total transaction of $39,842.88. Following the sale, the insider directly owned 69,773 shares of the company's stock, valued at approximately $478,642.78. This trade represents a 7.68% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Carlos Nueno sold 3,958 shares of the stock in a transaction dated Monday, June 2nd. The stock was sold at an average price of $6.86, for a total value of $27,151.88. Following the sale, the insider directly owned 17,645 shares in the company, valued at $121,044.70. This represents a 18.32% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 18,656 shares of company stock valued at $128,189. Company insiders own 0.58% of the company's stock.

Institutional Investors Weigh In On Teladoc Health

Hedge funds have recently modified their holdings of the company. Vanguard Group Inc. lifted its stake in Teladoc Health by 7.0% in the 1st quarter. Vanguard Group Inc. now owns 19,752,338 shares of the health services provider's stock valued at $157,229,000 after buying an additional 1,289,183 shares in the last quarter. Point72 Asset Management L.P. raised its holdings in Teladoc Health by 33.6% in the 4th quarter. Point72 Asset Management L.P. now owns 11,179,863 shares of the health services provider's stock valued at $101,625,000 after acquiring an additional 2,813,568 shares during the last quarter. Geode Capital Management LLC raised its holdings in Teladoc Health by 2.1% in the 2nd quarter. Geode Capital Management LLC now owns 4,150,197 shares of the health services provider's stock valued at $36,153,000 after acquiring an additional 84,356 shares during the last quarter. Maple Rock Capital Partners Inc. raised its holdings in Teladoc Health by 189.5% in the 4th quarter. Maple Rock Capital Partners Inc. now owns 3,561,000 shares of the health services provider's stock valued at $32,369,000 after acquiring an additional 2,331,000 shares during the last quarter. Finally, Dimensional Fund Advisors LP raised its holdings in Teladoc Health by 0.3% in the 4th quarter. Dimensional Fund Advisors LP now owns 3,531,492 shares of the health services provider's stock valued at $32,104,000 after acquiring an additional 8,890 shares during the last quarter. 76.82% of the stock is owned by hedge funds and other institutional investors.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.